Key result
Smooth muscle GLUT1 overexpression accelerates monocyte recruitment and advanced atherosclerosis in metabolic syndrome models.
Answers are grounded in this paper and cite their sources.
Metabolic syndrome contributes to cardiovascular disease partly through systemic risk factors. However, local processes in the artery wall are becoming increasingly recognized to exacerbate atherosclerosis both in mice and humans. We show that arterial smooth muscle cell (SMC) glucose metabolism markedly synergizes with metabolic syndrome in accelerating atherosclerosis progression, using a low-density lipoprotein receptor-deficient mouse model. SMCs in proximity to atherosclerotic lesions express increased levels of the glucose transporter GLUT1. Cytokines, such as TNF-α produced by lesioned arteries, promote GLUT1 expression in SMCs, which in turn increases expression of the chemokine CCL2 through increased glycolysis and the polyol pathway. Furthermore, overexpression of GLUT1 in SMCs, but not in myeloid cells, accelerates development of larger, more advanced lesions in a mouse model of metabolic syndrome, which also exhibits elevated levels of circulating Ly6Chi monocytes expressing the CCL2 receptor CCR2. Accordingly, monocyte tracing experiments demonstrate that targeted SMC GLUT1 overexpression promotes Ly6Chi monocyte recruitment to lesions. Strikingly, SMC-targeted GLUT1 overexpression fails to accelerate atherosclerosis in mice that do not exhibit the metabolic syndrome phenotype or monocytosis. These results reveal a potentially novel mechanism whereby arterial smooth muscle glucose metabolism synergizes with metabolic syndrome to accelerate monocyte recruitment and atherosclerosis progression.
No takes yet. Share an insight, caveat, or question.
Wall et al. (2018) studied Atherosclerosis and metabolic syndrome (preclinical mouse model). Arterial smooth muscle cell-targeted GLUT1 overexpression vs. Myeloid cell GLUT1 overexpression or absence of metabolic syndrome phenotype was evaluated on Atherosclerosis progression (lesion size and advancement) and Ly6Chi monocyte recruitment to lesions. Smooth muscle cell-targeted GLUT1 overexpression accelerated Ly6Chi monocyte recruitment and development of larger, more advanced atherosclerotic lesions in mice with metabolic syndrome.
Synapse has enriched 10 related papers. Consider them for comparative context: